-
Share
13/10/13
13:18
Share
Jatter,
You are on the money there. I am very confident that this one will have great success at the trial level.
The simplicity and rapidly transferable allogenic nature of the cynata patented technology could well be a hallmark stem cell play.
Many articles as per the release highlight the affects of the mab's.
Suggesting it is safe with fever the side effect ?
14m cap could be multiples of come end next year. News to the upside on this one.
Osiris takeover bodes well also
-